Thomas DesRosier
Director/Board Member at AVANIR PHARMACEUTICALS INC
Net worth: 93 327 $ as of 2024-03-30
Network origin in Thomas DesRosier first degree
Entity | Entity type | Industry | |
---|---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
155
| Subsidiary | Medical Specialties | 155 |
Public Company | Biotechnology | 35 | |
Holding Company | Pharmaceuticals: Major | 32 | |
25
| Public Company | Pharmaceuticals: Major | 25 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
Subsidiary | Biotechnology | 7 | |
Subsidiary | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Thomas DesRosier via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
CELGENE | Biotechnology | Director/Board Member Investor Relations Contact | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Sales & Marketing Corporate Officer/Principal Investor Relations Contact | |
Rochester Christian University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
DYAX CORP. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
MERSANA THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel Director/Board Member | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
VISTERRA INC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
University of Virginia | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member Director/Board Member Director/Board Member | |
University of Pennsylvania | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Director/Board Member Graduate Degree Doctorate Degree Undergraduate Degree | |
Brandeis University | College/University | Undergraduate Degree Doctorate Degree | |
Queens College | College/University | Graduate Degree Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree Corporate Officer/Principal | |
New York University | College/University | Masters Business Admin Corporate Officer/Principal | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The University of North Carolina at Chapel Hill | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Director/Board Member | |
The World Economic Forum USA, Inc.
The World Economic Forum USA, Inc. Miscellaneous Commercial ServicesCommercial Services The World Economic Forum USA, Inc. operates an organization for economic reforms. The non-profit company is based in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The private company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
CANDEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel | |
AXCA HEALPAR | Biotechnology | Director/Board Member Founder Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
Stanford Graduate School of Business | College/University | Doctorate Degree Masters Business Admin | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member Founder Director/Board Member | |
KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder Chief Executive Officer General Counsel Chief Executive Officer | |
MODERNA, INC. | Biotechnology | Director/Board Member Founder Director of Finance/CFO Director/Board Member | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistics
International
United States | 51 |
Sectoral
Health Technology | 28 |
Consumer Services | 18 |
Finance | 4 |
Commercial Services | 3 |
Health Services | 2 |
Operational
Director/Board Member | 656 |
Corporate Officer/Principal | 258 |
Independent Dir/Board Member | 209 |
Chairman | 178 |
Undergraduate Degree | 85 |
Most connected contacts
Insiders | |
---|---|
Noubar Afeyan | 75 |
Peter Hutt | 69 |
Carl Icahn | 57 |
Suet-Fern Lee | 36 |
Henry McKinnell | 35 |
Michael Bonney | 32 |
Robert Perez | 31 |
Lonnie Moulder | 31 |
Patrick Volkert Vink | 30 |
Roger Pomerantz | 30 |
Mark Corrigan | 29 |
Dennis Ausiello | 26 |
Marc Beer | 25 |
Alison Lawton | 24 |
Donald Hayden | 23 |
- Stock Market
- Insiders
- Thomas DesRosier
- Company connections